TP53 and melanoma: Notably, the mRNA expression of CDKN2A and BIRC5 (shown to be altered in P53 mutant melanoma cells) was significantly lower in melanocytes expressing control shRNA, suggesting that the inhibitory effect of P53 expression on these genes was relieved in cells expressing P53 shRNA (Table 4).